Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v3-EN
Language French English
Date Updated 2023-10-27 2023-10-20
Drug Identification Number 02229977 02229977
Brand name APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH APO-ACETAMINOPHEN CAPLETS EXTRA STRENGTH
Common or Proper name ACETAMINOPHEN ACETAMINOPHEN
Company Name APOTEX INC APOTEX INC
Ingredients ACETAMINOPHEN ACETAMINOPHEN
Strength(s) 500MG 500MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code N02BE N02BE
ATC description OTHER ANALGESICS AND ANTIPYRETICS OTHER ANALGESICS AND ANTIPYRETICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2023-09-26 2023-09-26
Estimated end date 2023-10-27 2023-10-27
Actual end date 2023-10-26
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments